Medication review in psychiatric patients with diabetes.
- Published in:
- Brown University Psychopharmacology Update, 2025, v. 36, n. 8, p. 2, doi. 10.1002/pu.31333
- By:
- Publication type:
- Article
Works by Lam, Y. W. Francis
Results: 241
1
2
Real‐world usage of paliperidone palmitate injection.
- Published in:
- Brown University Psychopharmacology Update, 2025, v. 36, n. 7, p. 2, doi. 10.1002/pu.31322
- By:
- Publication type:
- Article
3
Antidepressant use and stroke‐related outcomes.
- Published in:
- Brown University Psychopharmacology Update, 2025, v. 36, n. 6, p. 2, doi. 10.1002/pu.31309
- By:
- Publication type:
- Article
4
Psychotropic‐induced weight gain and telomere length.
- Published in:
- Brown University Psychopharmacology Update, 2025, v. 36, n. 5, p. 2, doi. 10.1002/pu.31299
- By:
- Publication type:
- Article
5
Psychotropic‐induced lipid disturbances.
- Published in:
- Brown University Psychopharmacology Update, 2025, v. 36, n. 4, p. 2, doi. 10.1002/pu.31286
- By:
- Publication type:
- Article
6
Drug‐associated neuroleptic malignant syndrome.
- Published in:
- Brown University Psychopharmacology Update, 2025, v. 36, n. 3, p. 2, doi. 10.1002/pu.31275
- By:
- Publication type:
- Article
7
Quetiapine co‐administration with fluvoxamine and duloxetine.
- Published in:
- Brown University Psychopharmacology Update, 2025, v. 36, n. 2, p. 2, doi. 10.1002/pu.31262
- By:
- Publication type:
- Article
8
Oxcarbazepine and clozapine interaction.
- Published in:
- Brown University Psychopharmacology Update, 2025, v. 36, n. 1, p. 2, doi. 10.1002/pu.31251
- By:
- Publication type:
- Article
9
Antidepressant use and dementia risk.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 12, p. 2, doi. 10.1002/pu.31237
- By:
- Publication type:
- Article
10
Antidepressants and changes in adiposity.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 11, p. 2, doi. 10.1002/pu.31225
- By:
- Publication type:
- Article
11
Antipsychotic‐associated breast cancer.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 10, p. 2, doi. 10.1002/pu.31212
- By:
- Publication type:
- Article
12
Drug interactions and pain control.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 9, p. 2, doi. 10.1002/pu.31200
- By:
- Publication type:
- Article
13
Appropriate use of anticholinergics.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 8, p. 2, doi. 10.1002/pu.31188
- By:
- Publication type:
- Article
14
Managing antipsychotic intolerance via genetics.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 7, p. 2, doi. 10.1002/pu.31177
- By:
- Publication type:
- Article
15
Pharmacological treatments for psychotic depression.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 6, p. 2, doi. 10.1002/pu.31164
- By:
- Publication type:
- Article
16
Lamotrigine and quetiapine interaction.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 5, p. 2, doi. 10.1002/pu.31154
- By:
- Publication type:
- Article
17
Neuropsychiatric effects of glucocorticoids.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 4, p. 2, doi. 10.1002/pu.31141
- By:
- Publication type:
- Article
18
Atomoxetine and bupropion interaction.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 3, p. 2, doi. 10.1002/pu.31131
- By:
- Publication type:
- Article
19
Reproductive safety of trazodone.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 2, p. 2, doi. 10.1002/pu.31118
- By:
- Publication type:
- Article
20
Clozapine‐associated myocarditis.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 1, p. 2, doi. 10.1002/pu.31107
- By:
- Publication type:
- Article
21
Dose‐related clozapine‐induced weight gain.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 12, p. 2, doi. 10.1002/pu.31095
- By:
- Publication type:
- Article
22
Neutropenia and thyroid dysfunction associated with lithium and clozapine therapy.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 11, p. 2, doi. 10.1002/pu.31084
- By:
- Publication type:
- Article
23
Valproate‐associated hyperammonemic encephalopathy.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 10, p. 2, doi. 10.1002/pu.31070
- By:
- Publication type:
- Article
24
Potentially inappropriate medications in the elderly.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 9, p. 2, doi. 10.1002/pu.31059
- By:
- Publication type:
- Article
25
Antidepressant use patterns in pregnancy.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 8, p. 2, doi. 10.1002/pu.31045
- By:
- Publication type:
- Article
26
Gastric bypass and antidepressant concentrations.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 7, p. 2, doi. 10.1002/pu.31034
- By:
- Publication type:
- Article
27
Pharmacogenomic screening and differential diagnosis of conversion disorder.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 6, p. 2, doi. 10.1002/pu.31021
- By:
- Publication type:
- Article
28
Drug‐drug interaction from self‐medication.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 5, p. 2, doi. 10.1002/pu.31009
- By:
- Publication type:
- Article
29
Risperidone dosing schedule.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 4, p. 2, doi. 10.1002/pu.30995
- By:
- Publication type:
- Article
30
Once‐ versus multiple‐daily dosing of clozapine.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 3, p. 2, doi. 10.1002/pu.30984
- By:
- Publication type:
- Article
31
Alprazolam safety in pregnancy.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 2, p. 2, doi. 10.1002/pu.30971
- By:
- Publication type:
- Article
32
Potential cinacalcet‐clozapine interaction.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 1, p. 2, doi. 10.1002/pu.30960
- By:
- Publication type:
- Article
33
Dosing options for clozapine.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 6, p. 2
- By:
- Publication type:
- Article
34
COVID-19 infection and psychotropics.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 8, p. 2, doi. 10.1002/pu.30753
- By:
- Publication type:
- Article
35
Eosinophilia associated with clozapine therapy.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 7, p. 2, doi. 10.1002/pu.30740
- By:
- Publication type:
- Article
36
Clozapine‐induced pancreatitis.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 6, p. 2, doi. 10.1002/pu.30727
- By:
- Publication type:
- Article
37
Polypharmacy in clozapine‐treated patients.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 5, p. 2, doi. 10.1002/pu.30715
- By:
- Publication type:
- Article
38
Pneumonia risk in patients receiving clozapine.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 3, p. 2, doi. 10.1002/pu.30665
- By:
- Publication type:
- Article
39
Altered clozapine bioavailability in patient with feeding tube.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 2, p. 2, doi. 10.1002/pu.30677
- By:
- Publication type:
- Article
40
Cardiovascular risks in patients receiving antidepressants.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 1, p. 2, doi. 10.1002/pu.30665
- By:
- Publication type:
- Article
41
Rhabdomyolysis associated with clozapine and haloperidol.
- Published in:
- Brown University Psychopharmacology Update, 2020, v. 31, n. 12, p. 2, doi. 10.1002/pu.30652
- By:
- Publication type:
- Article
42
Olanzapine and lithium interaction.
- Published in:
- Brown University Psychopharmacology Update, 2020, v. 31, n. 11, p. 2, doi. 10.1002/pu.30641
- By:
- Publication type:
- Article
43
Antidepressants and risk of Type 2 diabetes.
- Published in:
- Brown University Psychopharmacology Update, 2020, v. 31, n. 10, p. 2, doi. 10.1002/pu.30627
- By:
- Publication type:
- Article
44
Bleeding risk from antidepressants in patients with atrial fibrillation.
- Published in:
- Brown University Psychopharmacology Update, 2020, v. 31, n. 9, p. 2, doi. 10.1002/pu.30616
- By:
- Publication type:
- Article
45
Oral contraceptives and clozapine.
- Published in:
- Brown University Psychopharmacology Update, 2020, v. 31, n. 8, p. 2, doi. 10.1002/pu.30603
- By:
- Publication type:
- Article
46
Relationship between anticholinergic burden and mortality in the elderly.
- Published in:
- Brown University Psychopharmacology Update, 2020, v. 31, n. 7, p. 2, doi. 10.1002/pu.30593
- By:
- Publication type:
- Article
47
Association of cardiovascular events with antidepressants in the elderly.
- Published in:
- Brown University Psychopharmacology Update, 2020, v. 31, n. 6, p. 2, doi. 10.1002/pu.30580
- By:
- Publication type:
- Article
48
Hypothermia associated with use of paliperidone.
- Published in:
- Brown University Psychopharmacology Update, 2020, v. 31, n. 5, p. 2, doi. 10.1002/pu.30567
- By:
- Publication type:
- Article
49
Valproic acid and olanzapine concentration.
- Published in:
- Brown University Psychopharmacology Update, 2020, v. 31, n. 4, p. 2, doi. 10.1002/pu.30553
- By:
- Publication type:
- Article
50
Adverse drug events in elderly patients with Alzheimer's disease.
- Published in:
- Brown University Psychopharmacology Update, 2020, v. 31, n. 3, p. 2, doi. 10.1002/pu.30543
- By:
- Publication type:
- Article